Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)

American Journal of Kidney Diseases

Volumn 53, Issue 4 SUPPL. 4, 2009, Pages

  Bhuriya, Rohit ^a   Li, Suying ^b   Chen, Shu Cheng ^b   McCullough, Peter A ^c   Bakris, George L ^d  

^a The Chicago Medical College   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cardiovascular disease; chronic kidney disease; parathyroid hormone

Indexed keywords

CALCIUM; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LABORATORY TEST; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; SMOKING;

EID: 61749084092     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.11.029     Document Type: Article

References (34)

1. Keith D.S., Nichols G.A., Gullion C.M., et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
2. Lowrie E.G., and Lew N.L. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15 (1990) 458-482
3. Vanholder R., Massy Z., Argiles A., et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20 (2005) 1048-1056
4. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
5. Block G.A., Hulbert-Shearon T.E., Levin N.W., et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31 (1998) 607-617
6. Teng M., Wolf M., Ofsthun M.N., et al. Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16 (2005) 1115-1125
7. Moe S., Drueke T., Cunningham J., et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69 (2006) 1945-1953
8. Kamycheva E., Sundsfjord J., and Jorde R. Serum parathyroid hormone levels predict coronary heart disease: The Tromso Study. Eur J Cardiovasc Prev Rehabil 11 (2004) 69-74
9. Rostand S.G., and Drueke T.B. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56 (1999) 383-392
10. Usdin T.B., Bonner T.I., Harta G., et al. Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology 137 (1996) 4285-4297
11. Smogorzewski M. PTH, chronic renal failure and myocardium. Miner Electrolyte Metab 21 (1995) 55-62
12. Ogino K., Burkhoff D., and Bilezikian J.P. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136 (1995) 3024-3030
13. Schluter K.D., and Piper H.M. Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am J Physiol 263 (1992) H1739-H1746
14. Amann K., Ritz E., Wiest G., et al. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4 (1994) 1814-1819
15. Saleh F.N., Schirmer H., Sundsfjord J., et al. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24 (2003) 2054-2060
16. Akmal M., Kasim S.E., Soliman A.R., et al. Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int 37 (1990) 854-858
17. Liang K., Oveisi F., and Vaziri N.D. Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure. Kidney Int 53 (1998) 626-630
18. Akmal M., Massry S.G., Goldstein D.A., et al. Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 75 (1985) 1037-1044
19. Fadda G.Z., Hajjar S.M., Perna A.F., et al. On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 87 (1991) 255-261
20. Schleiffer R., Pernot F., and Jones R. Endothelium is a target organ of parathyroid secretions in genetic hypertensive rats. Horm Metab Res 27 (1995) 16-18
21. Noda M., Katoh T., Kurokawa K., et al. Increased expression of parathyroid hormone-related peptide gene in blood vessels of spontaneously hypertensive rats. Hypertension 30 (1997) 1284-1288
22. Barenbrock M., Spieker C., Laske V., et al. Studies of the vessel wall properties in hemodialysis patients. Kidney Int 45 (1994) 1397-1400
23. Rostand S.G., Sanders C., Kirk K.A., et al. Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 85 (1988) 651-657
24. Ejerblad S., Eriksson I., and Johansson H. Uraemic arterial disease. An experimental study with special reference to the effect of parathyroidectomy. Scand J Urol Nephrol 13 (2008) 161-169
25. Jurkovitz C.T., Qiu Y., Wang C., et al. The Kidney Early Evaluation Program (KEEP): Program design and demographic characteristics of the population. Am J Kidney Dis 51 suppl 2 (2008) S3-S12
26. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
27. Stevens L.A., and Stoycheff N. Standardization of serum creatinine and estimated glomerular filtration rate in the National Kidney Foundation Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 51 suppl 2 (2008) S77-S82
28. McCullough P.A., Jurkovitz C.T., Pergola P.E., et al. Independent components of chronic kidney disease as a cardiovascular risk state: Results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med 167 (2007) 1122-1129
29. Giovannucci E., Liu Y., Hollis B.W., et al. 25-Hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 168 (2008) 1174-1180
30. Andress D.L. Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation. Kidney Int 69 (2006) 33-43
31. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 (2008) 503-511
32. Martins D., Wolf M., Pan D., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167 (2007) 1159-1165
33. Joly D., Drueke T.B., Alberti C., et al. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: A cross-sectional study. Am J Kidney Dis 51 (2008) 987-995
34. Souberbielle J.C., Boutten A., Carlier M.C., et al. Inter-method variability in PTH measurement: Implication for the care of CKD patients. Kidney Int 70 (2006) 345-350